Skip to main content

Highlights

  1. 1
    Oncotarget · 2024
    PMID: 38275291PMCID: PMC10812235DOISenior author10 citations

Publications

293 publications

Active

1 grant
  • MPI
    A Phase 2 Trial of Darolutamide plus Leuprolide Acetate in Advanced Androgen Receptor Positive Salivary Gland Cancer
    NIH · 2026–2030 · via NIH RePORTER
Completed grants (2)
  • MPI
    Identifying and targeting neoantigens in aggressive salivary carcinomas
    NIDCR · 2018–2024 · via NIH RePORTER
  • PI
    Functionalizing recurrent FAT1 mutations and deletions in oral cancer
    NIDCR · 2014–2019 · via NIH RePORTER